Current Pharmaceutical Design
Volume 26, 46 Issues, 2020
ISSN: 1873-4286 (Online)
ISSN: 1381-6128 (Print)
This journal supports open access
ISSN: 1873-4286 (Online)
ISSN: 1381-6128 (Print)
This journal supports open access
Ranking and Category
-
148th of 267 in
Pharmacology & Pharmacy
   |
In the current Pandemic scenario, all articles related to Coronavirus will be processed on a free, quick track basis, to ensure timely review and publication of much needed research
Contents
Current Pharmaceutical Design, Volume 15 - Number 22
The Effects of Antipsychotics on the Brain: What Have We Learnt from Structural Imaging of Schizophrenia? – A Systematic Review
, 15(22): 2535 - 2549R. Smieskova, P. Fusar-Poli, P. Allen, K. Bendfeldt, R. D. Stieglitz, J. Drewe, E. W. Radue, P. K. McGuire, A. Riecher-Rossler and S. J. Borgwardt
DOI: 10.2174/138161209788957456
Mechanisms Underlying Psychosis and Antipsychotic Treatment Response in Schizophrenia: Insights from PET and SPECT Imaging
, 15(22): 2550 - 2559O. D. Howes, A. Egerton, V. Allan, P. McGuire, P. Stokes and S. Kapur
DOI: 10.2174/138161209788957528
Functional Imaging as a Tool to Investigate the Relationship between Genetic Variation and Response to Treatment with Antipsychotics
, 15(22): 2560 - 2572A. Di Giorgio, F. Sambataro and A. Bertolino
DOI: 10.2174/138161209788957483
What do ERPs and ERFs Reveal About the Effect of Antipsychotic Treatment on Cognition in Schizophrenia?
, 15(22): 2573 - 2593M. Korostenskaja and S. Kahkonen
DOI: 10.2174/138161209788957474
Imaging the Neural Effects of Cannabinoids: Current Status and Future Opportunities for Psychopharmacology
, 15(22): 2603 - 2614S. Bhattacharyya, J. A. Crippa, R. Martin-Santos, T. Winton-Brown and P. Fusar-Poli
DOI: 10.2174/138161209788957465
Connecting the Brain and New Drug Targets for Schizophrenia
, 15(22): 2615 - 2631H. C. Whalley, J. D. Steele, P. Mukherjee, L. Romaniuk, A. M. McIntosh, J. Hall and S. M. Lawrie
DOI: 10.2174/138161209788957500
Myelination in Bipolar Patients and the Effects of Mood Stabilizers on Brain Anatomy
, 15(22): 2632 - 2636Paolo Brambilla, Marcella Bellani, Ping-Hong Yeh and Jair C. Soares
DOI: 10.2174/138161209788957519
Neuroimaging and Genetics of Antidepressant Response to Sleep Deprivation: Implications for Drug Development
, 15(22): 2637 - 2649Francesco Benedetti and Enrico Smeraldi
DOI: 10.2174/138161209788957447
Editor-in-Chief
William A. Banks
(45093 citations)
Seattle VA Puget Sound Health Care System
Room 810C, Building 1
1660 S. Columbian Way
Seattle, WA 98108
(USA)
Biography
View Full Editorial Board
(45093 citations)
Seattle VA Puget Sound Health Care System
Room 810C, Building 1
1660 S. Columbian Way
Seattle, WA 98108
Biography
Biography of William A. Banks
Dr. Banks obtained his MD from the University of Missouri- Columbia and did clinical and research training at the Veterans Affairs Medical Center – New Orleans and Tulane University. He is currently Associate Chief of Staff –Research and Development at the Puget Sound VA and Professor of Medicine at University of Washington School of Medicine. His main interest is in blood-brain barrier function. He has published over 450 non-abstract articles, and over 20,000 citations according to Web of Science with an H-index fo 81.
Nobel Laureate on Editorial Board
Andrew V. Schally
(USA)
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Pharmaceutical Design was introduced in 1995 with the assistance of Dr. William A. Banks, who is the current Editor-in-Chief serving since 1995.
Scopus CiteScore Metrics: 2.32
Advertisement
Webmaster Contact: info@benthamscience.net